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Abstract
Aims/hypothesis Our recent studies suggest that activation
of the wingless-type MMTV integration site (WNT)
pathway plays pathogenic roles in diabetic retinopathy
and age-related macular degeneration. Here we investigated
the causative role of oxidative stress in retinal WNT
pathway activation in an experimental model of diabetes.
Methods Cultured retinal pigment epithelial cells and
retinal capillary endothelial cells were treated with a lipid
peroxidation product, 4-hydroxynonenal (HNE), and an
antioxidant, N-acetyl-cysteine (NAC). In vivo, rats with
streptozotocin-induced diabetes were treated by NAC for
8 weeks. Activation of the canonical WNT pathway was
measured by TOPFLASH assay and by western blot
analysis of WNT pathway components and a WNT target
gene, Ctgf. Oxidative stress in the retina was evaluated by
immunostaining of HNE and 3-nitrotyrosine.
Results Levels of phosphorylated and total LDL receptor-
related protein (LRP)6, and cytosolic β-catenin, as well as
transcriptional activity of T cell factor (TCF)/β-catenin
were significantly increased by HNE. The production of
connective tissue growth factor (CTGF) was also upregu-
lated by HNE. NAC blocked the WNT pathway activation
induced by HNE. Furthermore, LRP6 stability was increased
by HNE and decreased by NAC. Retinal levels of HNE and
3-nitrotyrosine were significantly increased in diabetic rats,
compared with those in non-diabetic rats. In the same
diabetic rat retinas, levels of LRP6, cytosolic β-catenin and
CTGF were significantly increased. NAC treatment reduced
HNE and 3-nitrotyrosine levels and attenuated the upregu-
lation of LRP6, β-catenin and CTGF in diabetic rat retina.
Conclusions/interpretation Lipid peroxidation products
activate the canonical WNT pathway through oxidative
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Introduction
Lipid peroxidation refers to the oxidative degradation of
lipids. Reactive oxygen species including superoxide anion
radical (O2
−), hydrogen peroxide (H2O2), hydroxyl radical
(OH
⋅), nitric oxide (NO
⋅) and peroxynitrite (ONOO
−⋅) are
most commonly involved in the initiation of lipid peroxida-
tion[1]. The most intensively investigated lipid peroxidation
product is 4-hydroxynonenal (HNE), a major oxidation
product of membrane lipids containing polyunsaturated n-6
acyl groups. HNE was initially identified as a toxic end-
product of lipid peroxidation, but later emerged as a
signalling mediator, which is involved in cell signal trans-
duction and regulation of gene expression [2]. Increasing
evidence has shown that tissue and blood levels of HNE are
higher in a number of human diseases, including chronic
inflammation, atherosclerosis, neurodegenerative diseases,
diabetes and different types of cancer. It has been suggested
that excessive HNE production could interfere with normal
signalling pathways and have a potential pathogenic role in
these diseases [3]. Besides the polyunsaturated fatty acids,
cholesterol may also undergo free radical-mediated oxida-
tion. One of the most important products of cholesterol
peroxidation is 7-ketocholesterol, which is a main compo-
nent of oxidised LDL and responsible for the cytotoxicity of
oxidised LDL [4].
The retina is highly susceptible to oxidative stress and
lipid peroxidation, as it has high levels of polyunsaturated
fatty acids, the highest oxygen consumption per gram of
tissue in the body and is also exposed to light [5]. Diabetic
retinopathy and age-related macular degeneration (AMD)
are leading causes of blindness in the USA [6, 7]. Although
several lines of evidence have shown that lipid peroxidation
products are important contributors to development of these
diseases [8–10], the precise molecular mechanism that
mediates the signalling transduction is still unclear.
The WNT signalling pathway is versatile, regulating cell
proliferation and differentiation, apoptosis, stem cell main-
tenance, angiogenesis, inflammation, fibrosis and carcino-
genesis [11]. WNT signalling had been shown to be a key
regulator of retinal development and has been implicated in
certain retinal diseases [12]. WNT ligands are secreted
cysteine-rich glycosylated proteins, which bind to a receptor
complex comprising the frizzled receptors and the LDL
receptor-related protein (LRP) 5 or 6. WNT ligand binding
leads to phosphorylation and activation of LRP6, which is
essential for WNT signalling. It also leads to inactivation of
‘destructive complex’, which is composed of glycogen
synthase kinase-3β (GSK3β), axin and adenomatous poly-
posis coli. Inactivation of the ‘destructive complex’ prevents
the proteosomal degradation of the transcriptional factor
β-catenin and promotes its accumulation and nuclear trans-
location. Once β-catenin translocates into the nucleus, it
associates with the T cell factor (TCF) and regulates
transcription of the WNT target genes, including VEGF
and CTGF [13–15].
Our previous studies have shown that the WNT pathway
is activated in retina from human patients with diabetic
retinopathy and in those from animal models of diabetes
[16]. The WNT pathway is also activated in an animal
model of AMD [17]. Moreover, blockade of WNT
signalling attenuates retinal inflammation and neovascular-
isation in diabetic retinopathy and in animal models of
AMD. These observations suggest that WNT pathway
activation in diabetic retinopathy and AMD contributes to
retinal inflammation and neovascularisation. The mecha-
nism responsible for WNT pathway activation in these
disease conditions is not clear.
The present study investigated the causative roles of
oxidative stress and subsequent lipid peroxidation products
inWNTpathwayactivationinAMDanddiabeticretinopathy.
Methods
Materials and antibodies HNE was purchased from
Calbiochem (Madison, WI, USA). N-Acetyl-cysteine (NAC),
hydrogen peroxide (H2O2), 7-ketocholesterol and cyclo-
heximide were purchased from Sigma (St Louis, MO,
USA). Normal human LDL and heavily oxidised glycated
LDL (HOG-LDL) were isolated and prepared following a
documented protocol [18]. Antibodies against β-catenin,
total-LRP6 and connective tissue growth factor (CTGF)
were from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). The antibodies against phosphorylated-LRP6
(pLRP6) were from Cell Signaling (Danvers, MA, USA)
and an anti-HNE adducts antibody was from Alpha
Diagnostic (San Antonio, TX, USA). Antibodies for
3-nitrotyrosine and β-actin, and horseradish peroxidase-
conjugated secondary antibodies were obtained from Abcam
(Cambridge, MA, USA). The 2F1 monoclonal antibody was
customer-generated through a contract with Protein-Tech
(Chicago, IL, USA). Conditioned media containing
wingless-type MMTV integration site family, member 3
(WNT3A) were prepared from mouse L cells (ATCC,
Manassas, VA, USA) stably producing WNT3A. Control
conditioned media were obtained from parental L cells.
Cell culture ARPE19 cell line was purchased from ATCC
and cultured according to the manufacturer’s protocol. Cells
in the 15th to 30th passages were used for all experiments.
Primary bovine retinal capillary endothelial cells (BRCEC)
460 Diabetologia (2011) 54:459–468were isolated and cultured as described previously [19].
Cells in the fifth to sixth passages were used for all
experiments.
Cell viability assay ARPE19 cells in 96-well plates were
treated with different stressors. Cell viability was measured
using a kit (Cell Counting Kit-8; Dujindu, Rockville, MD,
USA) according to the manufacturer’s protocol.
Dual-luciferasereporterassay TheTOPFLASH,FOPFLASH
plasmids from the TCF Reporter Plasmid Kit (Millipore,
Temecula, CA, USA) and renilla luciferase pRL-TK vectors
were co-transfected into ARPE19 cells according to manufac-
turer’s protocol. TOPFLASH, FOPFLASH activity was
measured using dual luciferase reporter system (Promega,
Madison, WI, USA) and normalised to renilla luciferase
activity.
Subcellular fractionation Cells were fractionated using
FractPrep (BioVision, Mountain View, CA, USA) following
the manufacturer’s protocol.
Western blot analysis Western blot analysis was performed
as described previously [17].
Animals and induction of diabetes in rats Female Brown
Norway rats (8 weeks of age) were purchased from Harlan
(Indianapolis, IN, USA). Care, use and treatment of all
animals in this study were in strict agreement with the
guidelines for the care and use of laboratory animals set
forth by the University of Oklahoma. Experimental diabetes
was induced as described previously [16].
Immunohistochemistry Immunohistochemistry was per-
formed as described previously [16]. Antibodies for
3-nitrotyrosine and HNE were used at a dilution of 1:200
and the antibody for β-catenin at a dilution of 1:300, with
incubation overnight. After thorough washes with PBS,
immunosignals were developed using a kit (Vectastain ABC;
Vector Laboratories, Burlingame, CA, USA) according to
the manufacturer’s protocol.
Statistical analysis Data are presented as means ± SD.
Comparisons were performed by two-tailed paired Student’s
t test. A value of p<0.05 was considered statistically
significant.
Results
7-Ketocholesterol, H2O2 and HNE activated the canonical
WNT pathway H2O2 is one of the initiators of lipid
peroxidation. 7-Ketocholesterol and HNE are the represen-
tative oxidation products of cholesterol and polyunsaturated
acid, respectively. To define the sub-lethal concentration
range of these three stimuli, ARPE19 cells were incubated
separately with 7-ketocholesterol, H2O2 and HNE at
various concentrations for 16 h. In the cells treated with
7-ketocholesterol, there was no cell viability change up to
10 μg/ml. At concentrations of 20–30 μg/ml, a slight
decrease in cell viability was observed (Fig. 1a). In the
H2O2-treated cells, cell viability was unaffected at up to
100 μmol/l. Cells incubated with 200 and 400 μmol/l of
H2O2 showed 20% and 80% decreases in viability,
respectively (Fig. 1b). However, in the HNE-treated cells
no loss in cell viability was observed at 5 and 10 μmol/l
(Fig. 1c). To exclude the possibility that the changes of the
WNT pathway activity were caused by decreased number
of viable cells, we chose concentrations that maintain most
cells viable, allowing us to investigate the effects of these
compoundsonthecanonicalWNTpathway.Theactivitiesof
the canonical WNT pathway were measured by TOPFLASH
assay, an activity assay for luciferase reporter, driven by a
Fig. 1 Effects of 7-ketocholesterol, H2O2 and HNE on cell viability
and TOPFLASH activity. a ARPE19 cells were treated with various
concentrations of 7-ketocholesterol (7-KC), (b)H 2O2 and (c) HNE for
16 h. Cell viability was determined using a commercial kit and
expressed as per cent of control cells. Values are mean ± SD, n=3;
*p<0.05 and **p<0.01. d ARPE19 cells were transfected for 8 h with
the TOPFLASH or FOPFLASH plasmid and then treated with various
concentrations of 7-ketocholesterol, (e)H 2O2 and (f) HNE for another
16 h. TOPFLASH activity (white bars) and FOPFLASH activity (grey
bars) were measured by luminometer and normalised to Renilla
luciferase activity. Values are mean ± SD, n=3;*p<0.05and**p<0.01
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in Fig. 1d–f, the transcriptional activities of TCF/β-catenin
were enhanced by 7-ketocholesterol, H2O2 and HNE in a
dose-dependent manner. To confirm that the effects were
dependent on TCF/β-catenin, we transfected the cells with
the negative control FOPFLASH vector, which contains a
scrambled DNA sequence of the TCF/β-catenin-binding
sites. 7-Ketocholesterol, H2O2 and HNE treatments did not
affect FOPFLASH activity. These results suggest that
various lipid peroxidation products from different origins
are causative factors for WNT signalling activation.
The canonical WNT pathway was activated by HNE To
elucidate the mechanism by which lipid peroxidation
products activate the canonical WNT pathway, HNE was
chosen as a representative lipid peroxidation product for the
mechanistic studies. As shown by western blot analysis,
phosphorylation of LRP6, an initial step in WNT pathway
activation, was increased by HNE in a concentration-
dependent fashion (Fig. 2a, b). Total LRP6, a co-receptor
of the WNT pathway, was also upregulated by HNE
(Fig. 2a, c).
In the canonical WNT pathway, β-catenin is phos-
phorylated by GSK3β in the absence of WNT ligands and
then degraded in the cytosol. GSK3β activity is regulated
by phosphorylation, e.g. phosphorylation at residue serine 9
(Ser9) is inhibitory to the kinase activity of GSK3β [20].
As shown in Fig. 2d, e, HNE induced an increase in
phosphorylation of GSK3β at Ser9, indicating a decreased
kinase activity of GSK3β. Consistently, cytosolic β-catenin
levels were increased significantly in cells treated with
HNE, compared with those in untreated cells (Fig. 2f, g),
indicating stabilisation of β-catenin.
NAC attenuated HNE-induced activation of the canonical
WNT pathway It has been reported that HNE-induced
Michael adduct formation can be blocked by pretreatment
with thiol protectant [21]. NAC is an antioxidant as well as
a thiol-protective agent. To determine whether the HNE-
induced activation of WNT signalling is due to oxidative
stress, we evaluated the effect of NAC on HNE-induced
WNT pathway activation. As shown by TOPFLASH assay,
the HNE-induced activity of the canonical WNT pathway
was ameliorated by the NAC treatment, while FOPFLASH
activity was not affected by these treatments (Fig. 3a). To
elucidate the mechanism by which NAC blocked HNE-
induced WNT activation, we measured phosphorylated and
total LRP6, showing that exposure of cells to HNE caused
an increase of phosphorylated and total LRP6 levels as
compared with those in control cells. Pretreatment of the
cells with NAC almost completely attenuated the induction
of phosphorylated and total LRP6 by HNE (Fig. 3b–d). We
also measured Lrp6 mRNA expression in cells exposed to
HNE, and to HNE together with NAC. Real-time RT-PCR
showed that there was no significant change of Lrp6
mRNA in the cells treated with HNE and HNE plus NAC
(data not shown), suggesting that regulation of LRP6 levels
by HNE did not occur at the transcription level.
Next, we examined the protein stability of LRP6 in the
cells treated with HNE and HNE plus NAC. We found that
the half-life of LRP6 is approximately 3 h in untreated
control cells. The HNE treatment significantly inhibited
degradation of LRP6, prolonging its half-life. This stabili-
sation of LRP6 by HNE was reversed by NAC, suggesting
that oxidative stress induces WNT pathway activation via
stabilisation of LRP6 (Fig. 3e, f).
Effect of NAC on WNT ligand-induced WNT signalling
NAC is a glutathione precursor and increases glutathione
Fig. 2 Activation of the canonical WNT pathway by HNE. ARPE19
cells were incubated with HNE for 6 h. a Levels of phosphorylated (p)
LRP6 and total LRP6 were determined by western blot analysis using
50 μg of total proteins from each sample. b Quantification of pLRP6
and (c) total LRP6 by densitometry from three independent experi-
ments, normalised to β-actin. d Levels of phosphorylated (p)GSK3β
(Ser9) and (f) cytosolic β-catenin were determined by western blot
analysis as above (a). e Quantification of pGSK3β (Ser9) and (g)
β-catenin levels by densitometry from three independent experiments,
normalised to β-actin or glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) levels. Values (b, c, e, g) are expressed as per cent of
control cells, given as mean ± SD, n=3; *p<0.05 and **p<0.01
462 Diabetologia (2011) 54:459–468levels [22]. A previous study reported that WNT or its
related signalling proteins are the major targets of glutathione
action [23]. Here we determined whether NAC affected the
WNT pathway activation induced by WNT ligands. ARPE19
cells were exposed to WNT3A-conditioned medium with or
without NAC for 6 h. Measurement of glutathione showed
that NAC treatment induced a significant increase of
glutathione levels (Fig. 4a). TOPFLASH assay showed that
NAC blocked WNT3A-induced TOPFLASH activity
(Fig. 4b). Furthermore, western blot analysis showed that
WNT3A induced a 2.5-fold increase of LRP6 phosphoryla-
tion, which was attenuated by NAC (Fig. 4c, d).
Level of CTGF was upregulated by HNE and inhibited by
NAC CTGF is one of the target genes regulated by the
WNT pathway [15] and plays a pathogenic role in retinal
diseases including diabetic retinopathy [24] and AMD [25].
To evaluate the pathogenic role of HNE in the regulation of
WNT target genes in these diseases, the effects of HNE and
NAC on CTGF levels were determined by western blot
analysis, which showed that HNE induced a sixfold
increase of CTGF levels, compared with control, while
NAC downregulated CTGF production in the HNE-treated
cells to a level similar to that in the untreated control
(Fig. 5a, b). To distinguish whether HNE-induced CTGF
production was through the canonical WNT pathway, we
generated a monoclonal antibody specific to LRP6, 2F1,
Fig. 4 Inhibitory effect of NAC on WNT3A-induced WNTsignalling.
a ARPE19 cells were pretreated for 1 h with NAC (1 mmol/l) prior to
incubation with WNT3A-conditioned medium for 6 h. Glutathione
(GSH) levels in the medium were measured using a commercial kit and
expressed as per cent of those in control medium. Values are mean ±
SD; n=3;**p<0.01. b ARPE19 cells were transfected for 8 h with the
TOPFLASH or FOPFLASH plasmid, and then pretreated for 1 h with
NAC (1 mmol/l) prior to incubation with WNT3A-conditioned
medium for another 16 h. TOPFLASH activity (white bars) and
FOPFLASH activity (grey bars) were measured by luminometer and
normalised to Renilla luciferase activity. Values are mean ± SD; n=3;
**p<0.01 for WNT3A compared with control;
†p<0.05 for WNT3A+
NAC compared with WNT3A. c Phosphorylated (p)LRP6 and total
LRP6 levels were determined with western blot analysis using 50 μgo f
total proteins from each sample. d pLRP6 was quantified by
densitometry from three independent experiments, normalised to
β-actin levels, and expressed as per cent of that in cells treated with
control L medium. Values are mean ± SD; n=3;**p<0.01 for WNT3A
compared with control;
††p<0.01 for WNT3A+NAC compared with
WNT3A
Fig. 3 Inhibition of HNE-induced WNT signalling by NAC.
a ARPE19 cells were transfected with TOPFLASH or FOPFLASH
plasmid for 8 h and then pretreated for 1 h with NAC (1 mmol/l) prior
to challenge with HNE (10 μmol/l) for another 16 h. TOPFLASH
activity (white bars) and FOPFLASH activity (grey bars) were
measured by luminometer and normalised to Renilla luciferase
activity. Values mean ± SD; n=3; *p<0.05 for HNE compared with
control;
†p<0.05 for HNE+NAC compared with HNE. b ARPE19
cells were pretreated for 1 h with NAC (1 mmol/l) prior to challenge
with HNE (10 μmol/l) for 6 h. Phosphorylated (p)LRP6 and total
LRP6 levels were determined by western blot analysis using 50 μgo f
total proteins from each sample. The blot is representative of three
independent experiments. c pLRP6 and (d) total LRP6 levels were
quantified by densitometry and normalised to β-actin levels. Values
are per cent of those in control cells, expressed as mean ± SD; n=3;
**p<0.01 for HNE compared with control;
†p<0.05 and
††p<0.01 for
HNE+NAC compared with HNE. e ARPE19 cells were pretreated for
1 h with NAC (1 mmol/l) prior to challenge with HNE (10 μmol/l) for
16 h, followed by addition of cycloheximide (50 μg/ml) to block
protein translation. Cells were collected at 0, 3, 5, 7 and 9 h following
the addition of cycloheximide (Chx0). Total LRP6 protein levels at
each time point were semi-quantified using western blot analysis,
normalised to β-actin levels and are expressed (f) as per cent of the
LRP6 levels prior to addition of cycloheximide. Blots (e)a r e
representative of three independent experiments. Values (f) are mean ±
SD; n=3. Diamonds, control; squares, HNE; triangles, HNE + NAC
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canonical WNT pathway. ARPE19 cells were pretreated
with the 2F1 antibody prior to HNE treatment. As shown
by the TOPFLASH assay, HNE-induced WNT activation
was inhibited significantly by the 2F1 antibody (Fig. 5c),
indicating a blockade of HNE-induced activation of the
canonical WNT pathway. Similarly, the CTGF production
induced by HNE was also downregulated by the 2F1
antibody (Fig. 5d, e), indicating that the induction of CTGF
by HNE was through the canonical WNT pathway.
β-Catenin was induced by HNE and HOG-LDL, and
blocked by NAC treatment in endothelial cells Dysfunction
of endothelial cells is a key pathological change in the
development of retinal diseases, especially in diabetic
retinopathy [7]. We have previously shown that oxidised
and glycated LDL is implicated in the initiation and
development of diabetic retinopathy [26]. Previous studies
in our group have shown that the canonical WNT pathway
is activated in diabetic retinopathy in human patients and
animal models of disease [16]. To determine the effect of
lipid peroxidation products on the WNT pathway in
endothelial cells, we measured the β-catenin level in
BRCEC exposed to HNE and HOG-LDL (20 μg/ml).
Western blot analysis showed that β-catenin levels were
elevated in the cells exposed to HNE or HOG-LDL,
compared with their respective control cells. NAC treat-
ment significantly blocked the increases of β-catenin levels
induced by HNE and HOG-LDL (Fig. 6a, b). These results
demonstrate that the pathogenic role of lipid peroxidation
products in diabetic retinopathy occurred partly through
activation of the WNT pathway.
Causative effects of oxidative stress on the WNT pathway in
the retina of diabetic rats It is well documented that
oxidative stress and lipid peroxidation products play
important roles in diabetic retinopathy, while inhibitors of
lipid peroxidation have beneficial effects in diabetic
complications [9, 16]. A recent study reported that NAC
treatment reduced free radicals and ameliorated early events
of diabetic retinopathy in a streptozotocin-induced animal
Fig. 5 CTGF wasinducedbyHNEand attenuatedbyNAC. a ARPE19
cells were pretreated for 1 h with NAC (1 mmol/l) prior to challenge
with HNE (10 μmol/l) for 6 h. CTGF levels were determined by
western blot analysis using 50 μg of total proteins from each sample.
CTGF was quantified (b) by densitometry from three independent
experiments, normalised to β-actin levels and expressed as per cent of
levels in control cells. Values mean ± SD; n=3; **p<0.01 for HNE
compared with control);
††p<0.01 for HNE+NAC compared with
HNE. c ARPE19 cells were transfected for 8 h with the TOPFLASH or
FOPFLASH plasmid and then pretreated with IgG or 2F1 (20 μg/ml)
for 1 h prior to incubation with HNE (10 μmol/l) for another 16 h.
TOPFLASH activity (white bars) and FOPFLASH activity (grey bars)
were measured by luminometer and normalised to Renilla luciferase
activity. Values are mean ± SD; n=3; **p<0.01 for HNE compared
with control;
††p<0.01 for HNE+2F1 compared with HNE. d ARPE19
cells were pretreated for 1 h with IgG or 2F1 (20 μg/ml) prior to
incubation with HNE (10 μmol/l) for 6 h. CTGF levels were
determined by western blot analysis using 50 μg of total proteins from
each sample. CTGF was quantified (e) by densitometry from three
independent experiments, normalised to β-actin levels and expressed as
per cent of levels in control cells. Values are mean ± SD; **p<0.01 for
HNE compared with control;
††p<0.01 for HNE+ 2F1 compared with
HNE
Fig. 6 β-Catenin levels were increased by HNE and HOG-LDL, and
decreased by NAC in BRCEC. a BRCEC were pretreated for 1 h with
NAC (1 mmol/l) prior to challenge with HNE (10 μmol/l). Cytosolic
β-catenin was measured by western blot analysis using 50 μgo f
proteins from each sample, normalised to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) levels and quantified in bar graph as per
cent of levels in control. Values are mean ± SD; n=3; **p<0.01 for
HNE compared with control;
††p<0.01 for HNE+NAC compared with
HNE. b BRCEC were treated with normal LDL (N-LDL) and HOG-
LDL (20 μg/ml) for 12 h. β-Catenin levels were determined by
western blot analysis using 50 μg of proteins from each sample,
normalised to β-actin levels and expressed as per cent of those in
control. Values are mean ± SD; n=3; **p<0.01 for HOG-LDL
compared with N-LDL;
†p<0.05 for HOG+NAC compared with
HOG-LDL
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WNT pathway is activated in the retina of streptozotocin-
induced diabetic rats and Akita mice [16]. To establish the
causative role of oxidative stress in WNT pathway
activation in diabetes, we assessed oxidative stress and
WNT pathway activities in the retina. Immunostaining of
the retinal sections showed that immunosignals of HNE and
3-nitrotyrosine, another oxidative stress maker [28], were
more intense in diabetic rats than in non-diabetic control
rats, suggesting an increase in oxidative stress and
subsequent lipid peroxidation in the retina of these rats.
Correlating with the increased oxidative stress, the intensity
of the β-catenin immunosignal was also increased in the
same diabetic retinas. NAC treatment (2 months) of the
diabetic rats significantly reduced HNE and 3-nitrotyrosine
in the retina of the diabetic rats (Fig. 7a). Consistent with
this, NAC treatment also decreased β-catenin levels in the
diabetic retina, compared with those in untreated diabetic
rat retinas. Western blot analysis confirmed that retinal
levels of 3-nitrotyrosine, total LRP6, β-catenin and CTGF
were upregulated in diabetic rats and reduced by NAC
treatment (Fig. 7b), suggesting that oxidative stress is a
causative factor in the canonical WNT pathway activation
in diabetic retinopathy.
Discussion
Our previous studies have shown that activation of the WNT
pathway plays a pathogenic role in diabetic retinopathy and
AMD [16, 17]. Accumulating evidence has demonstrated
that oxidative stress and lipid peroxidation are causative
factors of retinal diseases including diabetic retinopathy and
AMD [8–10]. Leakage and subsequent oxidation of plasma
lipoproteins in the retina may be implicated [26]. These
observations prompted us to hypothesise that oxidative stress
is a major cause of the WNT pathway activation in these
disease conditions. The present study demonstrates that
oxidative stress is responsible, at least in part, for the WNT
pathway activation in retina of diabetic rats. Our results also
show that several oxidants, including lipid peroxidation
products, activate the WNT pathway in cultured retinal cells
and endothelial cells. Mechanism studies indicate that these
oxidants activate the canonical WNT pathway via stabilisa-
tion of LRP6 and increasing of LRP6 levels. These results
for the first time elucidate the mechanism for WNT pathway
activation in diabetic retinopathy and AMD.
The WNT signalling pathway participates in angiogenesis
duringembryogenesisandinpathologicalprocessesinvolving
chronic inflammation and the development of tumours [29].
Recent evidence has linked the WNT pathway to vascular
growth in murine and human retina [16]. Previously, we
have shown that the WNT pathway is activated in retina
from human patients with diabetic retinopathy and in animal
models including streptozotocin-induced diabetic rats, Akita
mice and oxygen-induced retinopathy mice [16]. The WNT
pathway is also activated in VLDL receptor knockout mice,
a genetic model of AMD [30]. In addition, activation of the
WNT pathway alone in retinal pigment epithelial cells and in
retina of normal rats upregulated angiogenic and inflamma-
tory factors, including vascular endothelial growth factor,
TNF-α, intercellular adhesion molecule 1 and nuclear factor
kappa B [17]. A WNT signalling inhibitor ameliorated
inflammation and neovascularisation in animal models of
oxygen-induced retinopathy and AMD [16, 30]. These
results, together with the incipient investigation, established
the causative role of the WNT pathway in retinal neo-
vascularisation and inflammation in diabetic retinopathy and
AMD. Although compelling evidence revealed the role of
oxidative stress and lipid peroxidation products in retinal
diseases [8–10], no further studies were conducted to
Fig. 7 Effects of oxidative stress, lipid peroxidation products and
NAC on the WNT pathway in the retina of diabetic rats. a Normal rats
at 8 weeks of age received an intraperitoneal injection of streptozotocin
(50 mg/kg in 10 mmol/l of citrate buffer; pH 4.5) after an overnight fast.
Age-matched control rats received an injection of the citrate buffer alone
for non-diabetic control (Non-DM). NAC (1.4 g/kg) was administered
to diabetic groups (DM) in the drinking water for 8 weeks. The
ocular sections were immunostained separately with antibodies for
3-nitrotyrosine, HNE and β-catenin using DAB staining. GCL, Ganglion
celllayer;OPL,outerplexiformlayer.b The eyecups were dissected, and
levels of total LRP6, β-catenin and CTGF were determined by western
blot analysis using 50 μg of total proteins from each sample. Each lane
represents an individual animal. Wt, wild-type
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WNTpathwayactivationintheretina.Here,weunmaskedthe
intrinsic cause of WNT activation under these pathological
conditions. As shown here, hydrogen peroxide, one of the
initiatorsoflipidperoxidation,anddifferentlipidperoxidation
products (7-ketocholesterol, HNE, HOG-LDL) all activated
the WNT pathway. Moreover, the anti-oxidant NAC blocked
WNT pathway activation. These results established the
causative role of oxidative stress in WNT pathway activation
in diabetic retinopathy and AMD.
Oxidative stress is known to cause damage to nucleic
acid, proteins and lipids [2]. One of the prevalent aldehydes
generated is HNE, which is highly reactive and considered
an indicator of oxidative stress and messenger in cell
signalling. Due to chemical modification, HNE is able to
invoke different cell signalling pathways depending on its
concentration. At low and non-cytotoxic concentrations,
HNE regulates cell proliferation and signal transduction,
whereas at high concentrations it induces differentiation
and apoptosis [31]. It is well accepted that HNE participates
in the cell signalling that regulates inflammation, which
represents the main driving force in many chronic human
diseases. A large volume of data has clearly proved the
involvement of HNE in human pathological conditions [3].
Forinstance,HNE-derivedproteinmodificationsare involved
in lipofuscinogenesis and contribute to cell damaging effects
of lipofuscin inretinal diseases such as AMD [32]. Moreover,
concentrations of HNE in the plasma were significantly
elevated in patients with diabetic retinopathy in comparison
to diabetic patients without retinopathy [9]. Therefore, we
chose HNE as a representative lipid peroxidation product for
this study.
H2O2 is a reactive oxygen species as well as an initiator
of lipid peroxidation [1], and can alone cause a significant
increase of HNE adducts [33]. It is accepted that H2O2
modulates signalling pathways partly through its effects on
lipid peroxidation [31]. Our results show that H2O2 induced
over-activation of the canonical WNT pathway, indicating:
(1) that free radicals in oxidative stress and subsequent lipid
peroxidation are initial causative factors for activation of
the canonical WNT pathway; and (2) the possible involve-
ment of HNE in oxidative stress-mediated signalling. It is
well accepted that oxidative stress activates forkhead box
class O (FOXO) signalling; indeed, some publications have
concluded that FOXO and TCF proteins compete for the
limited pool of β-catenin under oxidative stress [34–37].
However, the interactions between the WNT signalling
pathway and oxidative stress remain controversial. Previ-
ously, Shin et al. reported that WNT signalling was
inhibited by a high concentration of H2O2 [38]. However,
Funato et al. showed that a low concentration of H2O2
induced rapid stabilisation of β-catenin and activation of
TCF in NIH3T3 or HEK293 cells, providing new insights
into the cross-talk between redox and the WNT/β-catenin
pathway [39]. With regard to HNE, it is well established
that HNE interferes with many signalling pathways, but
previous reports appear contradictory in some aspects. For
example, HNE (5 μmol/l) was found to induce early
neuronal cell death. Against this, Dozza et al. observed
that HNE (10 μmol/l) provoked significant inhibition of
GSK3β in human neuroblastoma IRM-32 cells [40]. The
disparity may be ascribed to the concentration of oxidants
and incubation time, as well as different cell types in these
studies.
Conjugation with glutathione is the main pathway for
HNE metabolism [3]. A deficiency of glutathione has been
found in several diseases including inflammation, diabetes,
cystic fibrosis, HIV, etc. NAC is the most effective and
versatile antioxidant among other commonly used anti-
oxidants, such as vitamin C, vitamin E and lipoic acid,
since NAC supplies the cysteine required for glutathione
synthesis and replenishment, reduces disulphide bonds in
proteins and scavenges free radicals [22]. Our in vitro
experiments showed that HNE-induced WNT pathway
activation was attenuated by NAC treatment, mainly through
blocking LRP6 phosphorylation and stabilisation induced by
HNE, indicating that NAC renders more glutathione to
conjugate HNE and prevents its interactions with target
proteins. Additionally, NAC also blocked WNT ligand-
inducedWNTactivation. Similarly, a previous study reported
that WNTs and related signalling proteins are the major
targets of glutathione action [23], strongly supporting the
notion that WNT signalling pathway is redox-sensitive and
that oxidative stress is a cause of WNT pathway activation.
Moreover, placebo-controlled trials have shown that oral
administration of NAC is beneficial in several diseases [22].
Our in vivo study presented here showed that NAC
treatment inhibits WNT pathway activation in retina of
diabetic rats and downregulates expression of a target gene
of WNT signalling. These findings suggest that blockade of
the WNT pathway by NAC may be a possible molecular
mechanism underlying its beneficial effects.
Regarding the mechanism underlying HNE-induced acti-
vation of the WNT pathway, we showed that HNE increases
phosphorylation of LRP6, an initial step in WNT pathway
activation. However, the mechanism by which HNE
increases phosphorylated LRP6 levels remains unclear. It is
known that WNT ligands lead to WNT–frizzled–LRP6
complex formation and LRP6 phosphorylation [41–43].
The hydroxyl group in HNE makes it highly reactive with
thiol of cysteine in proteins [3]. Moreover, some studies
have suggested that proteins cross-link via bridging by
HNE and subsequently become more resistant to proteol-
ysis [44]. Proteasome itself is a known target of HNE, and
HNE contributes to protein accumulation via impairment
of ubiquitin and/or proteasome-dependent intracellular
466 Diabetologia (2011) 54:459–468proteolysis [45]. Thus, one possible scenario is that HNE
modifies LRP6 or proteasome and inhibits LRP6 degrada-
tion. This assumption is supported by our LRP6 stability
assay, which showed that HNE inhibits LRP6 degradation
rather than upregulating its production. The increased
stability of LRP6 by HNE could contribute to the elevation
of LRP6 protein levels by HNE. Moreover, HNE can react
with nucleic acid and acts as a strong mutagen through a
clastogenic action. HNE covalently binds to DNA and
DNA-associated histones, which can affect the conforma-
tion of histones [3]. A documented study has reported that
the ability of HNE to alter DNA×histone interactions could
contribute to the vulnerability of DNA to oxidation, which
has been observed in the brain of Alzheimer patients [46].
The covalent and non-covalent modifications of DNA and
histone proteins, which is a well-known form of epigenetic
regulation, is one of the mechanisms that directly influence
chromatin structure [47]. Therefore, it is possible that
epigenetic alteration may contribute to the increase of
LRP6 protein content/phosphorylation by HNE. Since LRP6
phosphorylation itself involves multiple mechanisms and
many proteins [48, 49], the molecular mechanism under-
lying the HNE-mediated LRP phosphorylation warrants
further investigation.
In conclusion, our study established oxidative stress and
lipid peroxidation products as activators of the canonical
WNT pathway, a pathway that is pivotal in the pathogenesis
of diabetic retinopathy and AMD. Furthermore, this study
showed that the effect of HNE on the WNT signalling
pathway could be through stabilisation of the WNT co-
receptor, thus elucidating a pathogenic mechanism of HNE
in chronic diseases.
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